01 — The Case
The company and the disagreement.
lululemon athletica inc.
NASDAQ:LULU · US Domestic Issuer
Baseline: Interim report (working tables), period ending Aug 2
Analysis date
Oct 27, 2026
Share price
USD$102.91
20%
Below
55.1
-52.3%
In brief
Analysis date 2026-10-27
- What it does
- lululemon athletica designs, distributes and retails technical athletic apparel, footwear and accessories through company-operated stores and direct-to-consumer channels.
- What the market assumes
- The market prices the stock at a trailing P/E of 7.7x and an EV/EBITDA of 3.8x, implying a sharp fall in margins and growth.
- What the statements show
- The statements show a net-cash balance sheet, a 41.1% ROIC and free cash flow of $1.35B on $11.09B of revenue.
- What it is worth normally
- Expected value $129.2 against the $102.91 close, a 20% margin of safety; the Bear case prices it at $122.9.
- What would kill the thesis
- Americas comparable sales fall for two consecutive quarters. · Gross margin falls below 55% and stays there..
- Data basis
- Interim report (working tables) for the period ended 2026-08-02. the 2026-10-26 close.
- Standalone edition
- If a newer edition of this report on the same company is ever published, it is a separate product built on new filings, not an update to this one.
lululemon is a premium athletic apparel brand with a net-cash balance sheet and a 41.1% return on invested capital, now trading at 7.7x trailing earnings after a sharp repricing. The tension is between a maturing North American market and a still-growing international and direct-to-consumer business. The market and the statements disagree about whether the margin compression is temporary or structural.
What the market seems to assume
The current price of $102.91 implies an enterprise value of $9.48B, or 3.8x trailing EBITDA, which assumes margins and growth revert toward mid-single digits for years. The market is pricing a permanent impairment of the brand's pricing power.
What the statements show
The statements show TTM revenue of $11.09B growing 3.2% year on year, EBITDA of $2.52B, free cash flow of $1.35B and a net-cash position of $1.39B. ROIC is 41.1% and the balance sheet carries no borrowings.
Why this business looks healthy
- Net-cash balance sheet with no borrowings
- 41.1% ROIC on invested capital
- $1.35B of free cash flow
What to watch
- EBIT down 21.2% year on year
- North American demand softening
- Margin compression in FY2026
Bottom line
The business still earns well above its cost of capital; the question is whether the recent margin decline is reversible.
Risk and reward
The Bear, the expected value and the Bull against the price you would pay.
To the Bear
+19%
$122.9
Expected value
+26%
$129.2
To the Bull
+47%
$151.1
Reward / risk
no downside
the Bear sits above the price
02 — The Story
What the company does, why competitors can't copy it, and what the story gets wrong.
What they sell
lululemon designs, distributes and retails technical athletic apparel, footwear and accessories through company-operated stores and a direct-to-consumer channel. The company was founded in 1998 and is headquartered in Vancouver, Canada.
How they make money
Revenue comes from product sales through company-operated stores, e-commerce and a small wholesale and other segment. The model is capital-light relative to peers, with most growth funded from operating cash flow.
Segments
| Segment |
|---|
| Company-Operated Stores |
| Direct to Consumer |
| Other |
Premium athletic apparel is a crowded field with NIKE, Deckers, On Holding and Ralph Lauren competing for the same customer.
Porter's five forces
| Force | Pressure on profits |
|---|---|
| Rivalry | High |
| New entry | Moderate |
| Suppliers | Low |
| Merchants | Moderate |
| Substitution | Moderate |
Evidence for
- Brand loyalty and full-price selling
- 41.1% ROIC above most peers
- Direct-to-consumer mix supports margin
Evidence against
- North American demand slowing
- Promotional intensity rising
- Leadership turnover in 2026
The moat is narrow and possibly narrowing: pricing power is real but being tested by competitors and a softer consumer.
Management pitches a return to growth through product and leadership changes; the latest statements document falling EBIT and softer Americas demand. The score reflects partial support for the growth narrative.
03 — The Numbers
The key figures, three years of history, and whether to trust them.
In short
Four questions, four answers — the tables below show the work.
Where the money goes
TTM ending 2026-08-02 · USD
Widths to scale. Every percentage reads against revenue — the kept flows are the margins in the tables below: gross profit, operating profit, net income and free cash flow match their margins. The bars between them are arithmetic gaps between audited figures (EBITDA means operating profit before depreciation and amortization), shown so every bar balances. When interest income lifts net income above operating profit, the gap is shown as non-operating income rather than as a negative tax bill. A gap that measures zero drops out of the ladder rather than printing a phantom bar — same for a gross row that equals the top line.
USD · TTM to 2026-08-02 · FY = fiscal years · Balance sheet as of 2026-08-02 · Market priced 2026-10-27 · n.m. = not meaningful.
Income statement
Is it profitable, and is growth doing the work — or margins?
TTM revenue of $11.09B grew 3.2% year on year while operating income of $1.98B fell 21.2%, so the margin compression is the story, not the top line. Gross margin holds at 56.1% but operating margin slipped to 17.8%, and net margin is 12.8%. The single thing that would change this reading is a rebound in full-price selling in North America.
| Metric | TTM Aug '26 | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| $11.09B | $11.10B | $10.59B | $9.62B | |
| 56.1% | 56.6% | 59.2% | 58.3% | |
| 17.8% | 19.9% | 23.7% | 22.2% | |
| 12.8% | 14.2% | 17.1% | 16.1% | |
| 41.1% | 49.5% | 75.6% | 75.7% | |
| 29.6% | 31.8% | 42.0% | 36.6% |
Cash flow
Does profit arrive as cash, and what is reinvested?
TTM operating cash flow of $1.98B and free cash flow of $1.35B give a 12.2% FCF margin and 1.4x cash conversion, so profit turns into cash. Capex of $627.70M is about 5.7% of revenue. The single thing that would change this reading is a step-up in store or distribution investment.
| Metric | TTM Aug '26 | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| $1.35B | $921.68M | $1.58B | $1.64B | |
| 1.4x | 1.0x | 1.3x | 1.5x | |
| 12.2% | 8.3% | 15.0% | 17.1% |
Growth trend
Year-on-year change for each profit line.
Revenue CAGR of 11.0% over three years against EBIT down 21.2% year on year shows growth has not translated into profit growth recently. The single thing that would change this reading is a return to operating leverage.
| Metric | TTM Aug '26 | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| Revenue growth | 3.2% | 4.9% | 10.1% | 18.6% |
| EBIT growth | -21.2% | -11.8% | 17.5% | 60.5% |
| EPS Growth (1Y) | -21.6% | -9.4% | 20.0% | 82.6% |
| FCF growth | 3.0% | -41.8% | -3.7% | 401.6% |
Can it pay its debts?
TTM ending 2026-08-02 · USD
No borrowings — cash of $1.39B leaves $1.39B of net cash. There is nothing to refinance, so no debt bridge is drawn.
What funds the assets?
TTM ending 2026-08-02 · USD
Equity funded 56.5% of assets at Aug '26, down from 59.7% in FY2024 — funding leaned toward debt.
What kind of machine
Capital intensity is moderate: TTM capex of $627.70M on $11.09B of revenue, or about 5.7% of sales.
Where earnings sit
The business is past peak growth: revenue CAGR of 11.0% over three years but EBIT down 21.2% year on year.
Balance sheetFortress
How much cushion before trouble — and where is it moving?
The balance sheet carries no borrowings and $1.39B of cash against $4.79B of equity, a current ratio of 2.2x and net debt of negative $1.39B. ROIC is 41.1% and ROE 29.6%. The single thing that would change this reading is a large acquisition funded with debt.
| Metric | As of Oct '26 | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| 2.2x | 2.3x | 2.2x | 2.5x | |
| 0.0x | 0.0x | 0.0x | 0.0x | |
| -0.6x | -0.7x | -0.7x | -0.9x | |
| 106M | — | — | — |
Market pricing
What each dollar of sales, cash and earnings costs.
Each $1 of trailing free cash costs $8.02 (a 12.5% yield); each $1 of sales costs $0.98.
Priced 52.3% below its 52-week high and below its 200-day average.
The stock trades at 7.7x trailing earnings, 3.8x EV/EBITDA and 8.0x price to free cash flow, a 12.5% FCF yield. The market is pricing a deep and lasting margin decline. The single thing that would change this reading is evidence that North American demand has stabilised.
| Metric | Current Oct '26 | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| $10.87B | $20.78B | $51.33B | $57.66B | |
| $9.48B | $18.97B | $49.35B | $55.42B | |
| 7.7x | 13.2x | 28.3x | 37.2x | |
| 4.8x | 8.6x | 19.7x | 26.0x | |
| 3.8x | 7.0x | 16.7x | 22.1x | |
| 8.0x | 22.5x | 32.4x | 35.1x | |
| 1.0x | 1.9x | 4.8x | 6.0x | |
| 2.3x | 4.2x | 11.9x | 13.6x | |
| 12.5% | 4.4% | 3.1% | 2.9% |
Ownership and dilution
A rising share count divides the same cash among more owners.
- Shares outstanding
105.6M (latest)
no prior-year cover counts in this run, so the trend cannot be shown
- Stock-based compensation
Not carried by this run
the cash-flow add-back could not be read from the filings; the gap is named, not estimated
The run carries the latest share count (105.6M) but no prior-year cover counts, so the trend cannot be shown. The SBC line is the other half of the dilution reading; where the filings do not carry it, the gap is named rather than guessed.
Accounting quality
Scale A (clean) → F (major concerns): cash conversion, one-offs, and balance-sheet clarity.
Why this grade: Cash conversion is strong, supporting the grade; the undisclosed customer-company split of the cash line limits it; clearer disclosure of the cash composition would raise it.
Cash test — does profit arrive as cash?
TTM operating cash flow of $1.98B against net income of $1.42B gives a cash conversion of 1.4x, so reported profit turns into cash.
One-offs — what flatters or dents this year?
No large one-time items are flagged in the TTM figures; restructuring is already inside operating income.
Balance-sheet clarity — what could mislead?
The balance sheet carries no borrowings and $1.39B of cash; the customer-company split of that cash is not disclosed.
04 — What It's Worth
What you pay versus what you get.
Margin of safety
Current price, probability-weighted value, and the gap between them.
20%
- Tail$8.9
- Oct 27 price$102.91
- Bear$122.9
- Base$135.7
- Bull$151.1
Each case is defined in the scenario table below — key assumptions, what must hold, and what breaks it.
What the price implies
The same forecast, exit multiple and no-growth blend, at our rate and at the rate the price implies.
Our rate10.0%
$129.2 20% margin
The market's rate15.7%
$96.9 -6% margin
The market's rate is solved from the price against the published cash path, with no growth after year five.
The business is priced two ways
- The exit reading projects growing cash, discounts it back to today, and prices what a buyer could pay for the horizon year's cash.
- The perpetuity reading asks what today's cash alone is worth if nothing ever grows.
Both readings price the same cash off the same computed rate; the published value is a deliberate blend of the two — one number by house convention, not two independent votes.
Exit readingExitEvaluated per-share value$130.1
Inputs and assumptions
Methodexit
Horizon Years5.0
0.04,0.03,0.02,0.015,0.01
Why: Year 1 anchored to FY2026 (revenue +4.9% YoY to $11.10B but EBITDA -8.3% to $2.71B and net income -13.0% to $1.58B) with a modest stabilization assumption: FCF conversion held near the trailing filed ~34% (FY2026 FCF $0.92B / EBITDA $2.71B). Growth then fades 1pp per year toward a 1% terminal as the company's store expansion and China growth normalize against a maturing North American base.
0.05,0.04,0.025,0.02,0.01
Why: Year 1 anchored to FY2026 EBITDA of $2.71B (-8.3% YoY) with a 5% recovery as promotional intensity and freight costs ease; fades 1-1.5pp per year to 1% as revenue growth settles into the low-single digits and gross margin stabilizes near 56%.
DCF values the business in the following steps:
- Estimate free cash flow (FCF) for the next 5 years, starting from current trailing cash, then shrink each year's FCF to its current value with the cost of capital. (See Year-by-year cash table.)
- Estimate a terminal value of the business after year 5 — the presumed sale price of the whole business. Then shrink the terminal value to its current value at the compounded cost of capital.
- Determine the enterprise value by adding the discounted yearly cash and the discounted terminal value.
- Determine the equity value by subtracting the net debt from the enterprise value.
- Get the evaluated per-share value by dividing equity value by shares outstanding.
The five-year forecast
| Year | FCF growth | FCF | Discounted FCF |
|---|---|---|---|
| 1 | 4.0% | $1.41B | $1.28B |
| 2 | 3.0% | $1.45B | $1.20B |
| 3 | 2.0% | $1.48B | $1.11B |
| 4 | 1.5% | $1.50B | $1.03B |
| 5 | 1.0% | $1.52B | $941.93M |
| Total $5.56B | |||
Year-by-year EBITDA
| Year | EBITDA growth | EBITDA | Discounted EBITDA |
|---|---|---|---|
| 1 | 5.0% | $2.64B | $2.40B |
| 2 | 4.0% | $2.75B | $2.27B |
| 3 | 2.5% | $2.82B | $2.12B |
| 4 | 2.0% | $2.88B | $1.96B |
| 5 | 1.0% | $2.90B | $1.80B |
| Terminal value = 3.8 × $1.80B = $6.79B | |||
Discounted FCFs $5.56B + Terminal Value $6.79B =
Enterprise value $12.34B
PV of 5Y FCF + PV(Exit: 3.8X X Year-5 Ebitda $2.90B (The Market'S Trailing Multiple, Held)) − Net Debt, Per Share =
Per-share value $130.1
Perpetuity readingPerpetuityEvaluated per-share value$141.4
Inputs and assumptions
0.0%
Why: the perpetuity reading normalizes the trailing cash flow $1.35B toward the issuer's own filed years — FY2024 $1.64B, FY2025 $1.58B, FY2026 $921.68M — averaging $1.38B; the cut is 0.0% (computed, inside the 0-25.0% policy band), not chosen
NoteThe perpetuity reading normalizes the trailing cash flow toward the issuer's own filed years; the cut is computed by the engine.
10.0%
Why:
EPV values the business in the following steps:
- Normalize current free cash flow (FCF): start from trailing cash $1.35B and apply the stated safety cut. The Safety cut box above states the chosen rate and what caused it. The result is the yearly cash treated as repeatable with no growth.
- Turn that yearly cash into one lump sum: the deposit that would pay out the same cash every year forever at the cost of capital, without ever shrinking. That deposit is the enterprise value — what today's cash alone is worth if nothing ever grows.
- Determine the equity value by subtracting the net debt from the enterprise value.
- Get the evaluated per-share value by dividing the equity value by shares outstanding.
Trailing Cash $1.35B - Safety Cut 0.0% =
Normalized cash $1.35B
Normalized Cash $1.35B / Cost Of Capital 10% =
Enterprise value $13.54B
(Fcf TTM × (1 − Haircut Pct)) / Cost of Capital − Net Debt, Per Share =
Per-share value $141.4
Reality check
The two published readings blend into $135.7. History paid well above that — the market used to believe more.
History-paid valueWhat the market used to pay$411.8
The Middle Of The Fiscal-Year EV/EBITDA(2.52B) History X TTM(2.52B) EBITDA(2.52B), Less net(-1.39B) debt(-1.39B), Per share(105.59M) — History-paid: the multiple the market itself paid in the middle year of the three-year history, applied to today's earnings.
also: Fair Multiple 16.7161
Scenario weights
Each case's weight in the final expected value, and the variables each case changes versus the blend's exit reading, which are: FCF growth 4.0% → 1.0%, exit multiple 3.8×, cost of capital 10.0%. Base is the deliberate blend of the two readings; the rest stress the exit reading's cash path, except Tail — the extreme breakage case — which also cuts the starting cash and earnings themselves.
Bull
20.0%Exit multiple 4.8×$151.1
Base
50.0%Deliberate blend: exit reading and perpetuity reading averaged$135.7
Bear
25.0%Exit multiple 2.8×$122.9
Tail Risk
5.0%Exit multiple 2.3×$8.9
Scenario Analysis
| Scenario | Why this weight | What it assumes | What must be true | What breaks it |
|---|---|---|---|---|
| Bull | 20%: requires a full margin recovery and re-acceleration of China growth. | Revenue re-accelerates to high-single digits; gross margin recovers toward 58%; EBITDA margin returns to ~26%. | North American demand stabilizes and China growth re-accelerates above 20%. | Promotional intensity rises, compressing gross margin below 55%. |
| Base | 50%: the modal outcome given the filed deceleration. | Revenue grows low-single digits; EBITDA grows 5% then fades to 1%; FCF conversion stays near 34%. | Store growth and China expansion offset North American softness. | A sustained demand decline in the core North American market. |
| Bear | 25%: meaningful probability that pricing power erodes. | Revenue flattens; EBITDA declines modestly; FCF conversion falls toward 25%. | The consumer trade-down persists and competitors capture share. | A successful product reset or demand rebound. |
| Tail Risk | 5%: a brand-damage scenario; kept above zero per the model's practice. | EBITDA troughs at 25% of TTM EBITDA; net cash takes a 10% forced-sale haircut. | A severe demand collapse and permanent brand impairment. | Brand equity proves durable and demand recovers within two seasons. |
Against the sector backdrop
| Measure | Company TTM | Peers median |
|---|---|---|
| 7.7x | 18.2x | |
| 3.8x | 9.5x | |
| -0.6x | -0.2x | |
| 12.5% | 7.0% | |
| 17.8% | 14.9% | |
| 41.1% | 48.9% | |
| 3.2% | 7.9% |
Against the peer median, lululemon trades at a lower P/E and EV/EBITDA but a higher ROIC, consistent with a market that doubts the durability of its growth. The peer medians blend different business models, so read them as backdrop rather than a benchmark.
How sensitive is the value?
One assumption moves, everything else holds still — per-share moves.
| Shock | Discounted cash flow | No-growth value |
|---|---|---|
| rate +1pp | -4.18 | -11.66 |
| rate -1pp | 4.39 | 14.25 |
| cash +10% ($138.97M) | 1.32 | 1.32 |
| cash -10% ($138.97M) | -1.32 | -1.32 |
| exit multiple +1.0x | 17.08 | — |
| exit multiple -1.0x | -17.08 | — |
A one-point move in the discount rate changes the DCF value by about 4.2% and the perpetuity reading by 11.7%; the precision band spans $125.4 to $133.7. The discount rate is the largest single swing.
05 — What Could Go Wrong
Biggest risks first, what breaks the thesis, then what to watch.
Ranked risks
- 01
North American demand collapse
If north American demand collapses and promotional intensity rises.
Watch americas comparable sales decline for two consecutive quarters.
High
Taken into account for Bear and Tail scenarios$122.9 / $8.9
Thesis breaks if
- Americas Comparable Sales < 0 · two consecutive quarters
- 02
Margin compression becomes structural
If gross margin falls below 55% and stays there.
Watch gross margin below 55% for two consecutive quarters.
High
Taken into account for Bear and Tail scenarios$122.9 / $8.9
Thesis breaks if
- Gross Margin < 0.55 · two consecutive quarters
- 03
China growth stalls
If china growth slows below 10%.
Watch china revenue growth below 10% in a quarter.
Medium
Taken into account for Bear scenario$122.9
Thesis breaks if
- China Revenue Growth < 0.1 · two consecutive quarters
- 04
Leadership execution risk
If new leadership fails to stabilise product and demand.
Watch further executive departures within twelve months.
Medium
Taken into account for Bear scenario$122.9
Thesis breaks if
- Executive Departures > 0 · twelve months
- 05
Competitive share loss
If alo Yoga and others take share in premium activewear.
Watch market share data showing share loss to Alo Yoga.
Low
Taken into account for Bear scenario$122.9
Thesis breaks if
- Market Share < 0 · annual
pre-mortem
If we're wrong, this is probably why
By 2029 the most likely error is that the margin compression proved structural rather than cyclical, pushing the outcome toward the bear case. The tail case applies if brand impairment forced store closures.
You'd see it first in: Americas comparable sales decline for two consecutive quarters.
That world is the $122.9 Bear / $8.9 Tail world in section 04.
What we're tracking
Neutral timing markers — earnings, payouts, execution milestones. Not thesis drivers.
- Dec 11, 2026Q3 2026 earnings report (filed calendar)
What the market is talking about
Rumors and reported speculation — shown so you know what circulates, not what to believe. Never part of the valuation.
reported Lululemon's Americas sales slump deepens turnaround concerns (2026-10-21)
reported Lululemon downgraded by a research firm (2026-10-22)
reported Alo Yoga's rise is pressuring Lululemon and other athletic apparel brands (2026-10-16)
06 — People & Capital
Are the people in charge good stewards of the business?
lululemon appointed Maggie Gauger as President and Chief Product Officer and Joseph Godsey as Chief Operating Officer on 2026-10-07, while Nikki Neuburger and Ted Dagnese departed. Tara Poseley was appointed to the board on 2026-10-22.
The company carries no borrowings and holds $1.39B of cash. No dividends are paid; repurchases are funded from cash flow rather than debt.
Management grades
| Category | Grade | Justification |
|---|---|---|
| Execution | B | Revenue still growing but EBIT fell 21.2% year on year; the grade would rise if margins recover in the next two quarters. |
| capital allocation | A | Net-cash balance sheet, no debt-funded buybacks; it would fall if a large acquisition were debt-funded. |
| integrity & incentives | B | Leadership reshuffle in 2026; pay versus performance to be watched; it would rise if pay growth tracks earnings growth. |
07 — Conclusion
The final read.
The expected value of $129.2 against a price of $102.91 is a 20% margin of safety. The bear case prices the stock at $122.9, still above the price, so the margin erodes but does not invert. The main uncertainty is whether North American demand has stabilised, observable in the next two quarters of comparable sales.
Why the market might be wrong — and how this could fail
The market prices a permanent margin impairment at 7.7x trailing earnings, but the statements show a net-cash balance sheet, 41.1% ROIC and $1.35B of free cash flow. The bear case still prices above the current price, so the downside is bounded unless brand impairment sets in. The health tension is cash strength on one side and margin fragility on the other. Watch Americas comparable sales.
Method & data gaps
Temporal context
The figures come from the working tables' newest reported period, for the period ended 2026-08-02. The price is the close of 2026-10-26, the last completed session before this report was written on 2026-10-27. Figures are as of the TTM period ended 2026-08-02 and the price close of 2026-10-26; no newer filing exists beyond those dates.
Missing data
- Stock-based compensation not carried in the working-tables history. Impact: SBC memo cannot be quantified.
- No interest expense line in the filed statements. Impact: Interest cover is not meaningful; the company carries no borrowings.